HOME
Hepatitis B
Hepatitis C
HIV and AIDS
HIV-HCV Coinfection
HIV-HBV Coinfection
Hepatitis B Main Section
FDA-approved Treatments
 Experimental Treatments
 HBV Articles by Topic

HBV - Hepatocellular Carcinoma

Hepatocellular Carcinoma Rates Vary Widely Across Sex and Racial/Ethnic Groups - 7/25/08

Two Studies Look at Promising Therapies for Liver Cancer - 7/25/08

HBV and Hepatocellular Carcinoma Recurrence after Resection Surgery and Liver Transplantation - 7/25/08

R.E.V.E.A.L.-HBV StudyShows Persistently High Hepatitis B Viral Load Raises the Risk of Liver Cancer - 4/29/08

Occult Hepatitis B Virus in Individuals without Liver Disease - 3/14/08

Relation between HBV "X" Gene Integration and Development of Hepatocellular Carcinoma - 1/14/08

Sorafenib (Nexavar) Demonstrates Promising Results for Hepatocellular Carcinoma - 9/07/07

Factors Associated with Development of Hepatocellular Carcinoma in Chronic Hepatitis B Patients  - 5/11/07

Interferon Lowers Tumor Recurrence Rate after Treatment of Hepatocellular Carcinoma   2/20/07

Differences Between Hepatocellular Carcinoma Related to Hepatitis B Genotypes B and C 1/23/07

Colchicine Delays the Development of Hepatocellular Carcinoma in Patients with Chronic Viral Hepatitis 10/17/06

Factors Associated with Progression to Cirrhosis and Liver Cancer - 6/06/06

New Compound May Protect Against Liver Cancer - 2/28/06

Preventive Treatment for Hepatitis B Helps Avoid Relapse during Chemotherapy for Cancer - 12/16/05

What Factors Predict Survival in Patients with Hepatocellular Carcinoma and Cirrhosis Who Receive Liver Transplants? - 10/17/05


 

 

 

 

 

 

 


HBV Articles on
FDA-approved Therapies
for Chronic HBV Infection

Baraclude  (entecavir)
 Epivir-HBV  (lamivudine; 3TC)
 Hepsera   (adefovir dipivoxil)
Intron A  (interferon alfa-2b)
Pegasys  (peginterferon alfa-2a)
 Tyzeka   (telbivudine)